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CAGEVery large microarray datasets showing gene expression across multiple tissues and cell populations provide a
window on the transcriptional networks that underpin the differences in functional activity between biological
systems. Clusters of co-expressed genes provide lineage markers, candidate regulators of cell function and, by
applying the principle of guilt by association, candidate functions for genes of currently unknown function. We
have analysed a dataset comprising pure cell populations from hemopoietic and non-hemopoietic cell types
(http://biogps.gnf.org). Using a novel network visualisation and clustering approach, we demonstrate that it is
possible to identify very tight expression signatures associated speciﬁcally with embryonic stem cells,
mesenchymal cells and hematopoietic lineages. Selected examples validate the prediction that gene function
can be inferred by co-expression. One expression cluster was enriched in phagocytes, which, alongside
endosome-lysosome constituents, contains genes that may make up a ‘pathway’ for phagocyte differentiation.
Promoters of these genes are enriched for binding sites for the ETS/PU.1 and MITF families. Another cluster was
associated with the production of a speciﬁc extracellular matrix, with high levels of gene expression shared by
cells of mesenchymal origin (ﬁbroblasts, adipocytes, osteoblasts and myoblasts). We discuss the limitations
placed upon such data by the presence of alternative promoters with distinct tissue speciﬁcity within many
protein-coding genes.Biocentre, Roslin EH25 9PS,
ume).
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If two or more proteins participate in a common cellular process or
pathway, the operation of that pathway will depend on the genes
encoding theseproteinsbeingexpressed ina coordinatedmanner.Niehrs
and Pollet [1] extended the concept of the operon from bacteria, and
coined the term "synexpression group" for sets of genes in eukaryotes
that are coordinately expressed because they are required for a particular
function. Their initial observation arose from studies of spatiotemporal
expression of genes required for development of Xenopus embryos. They
suggested that, as in bacteria, geneswith co-ordinated expressionwould
share upstream master regulators that act in some form of hierarchy to
control target gene expression. This presumed that there is a determin-
istic basis for co-expression of any twogeneswithin a particular cell type.
However, co-expression can also arise by chance through the combined
probabilities of each gene being expressed in a population, since gene
expression is intrinsically binary and probabilistic [2]. So, for example,
manymulticolour FACS proﬁles on lymphoid ormyeloid cell populationscan be interpreted as the random intersection of two distributions [3],
rather than evidence of shared function. Evidence of strict co-expression
requires the analysis of very large datasets in which cells are examined
under a wide range of conditions.
The comprehensive deﬁnition of the transcriptome of several mam-
mals, especially the mouse [4,5] and the advent, and subsequent rapidly-
decreasing costs, of microarray technologies, has altered our ability to
analyse the transcriptional landscape. There are several hundred iden-
tiﬁed specialised cell types that make up the complex biology of a mam-
mal [6] and each of them would be expected to have a gene expression
proﬁle that enables them to perform their specialised role. Some evidence
in favourof this expectation arose fromapioneering effort by Suet al. [7,8]
in establishing the SymAtlas datasets, in which the protein-encoding
transcriptomes of most major organs of the body of mouse and human
were analysed using Affymetrix microarrays. These and other large scale
datasets from tumor cell lineswere integratedbyAla et al. [9] to produce a
conserved co-expression matrix across mouse and human organs and
cellular systems. By identifying clusters in which one or more members
generated a human disease, the authors could predict additional human
disease genes that affect the same organ system or process.
Tissue expression proﬁles represent a mix of cellular markers of the
major cell types in the tissue, so the signal to noise ratio is relatively high
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induced when macrophages respond to an innate immune stimulus
[10,11] are not effectively sampled. Over the past fewyears, a number of
smaller scale efforts have attempted to deﬁne the specialised gene
expression proﬁles of cells within the hemopoietic lineages in various
states of differentiation and activation. Amongst these efforts, there
have been several studies of isolated progenitor cells, aiming to identify
the genes associated with "stemness", the capacity for self-renewal, to
ﬁnd additional markers thatwould enable isolation of these rare cells in
high yield and purity for transplantation or in vitro regeneration [12].
Others have compared proﬁles of cells of the innate and acquired
immune system in various states of activation or differentiation [13].
There are now a number of consortia working on comparative analyses
of the transcriptome of immune cell populations in various states of
activation, at the same time developing new web interfaces [14–16].
The latest update of SymAtlas (called BioGPS; http://biogps.gnf.org)
contains an extensive set of replicated Affymetrix gene expression data
generated fromawide range ofmouse cell types. These include isolated,
puriﬁed hemopoietic precursors and mature cell populations, analysed
alongside multiple non-hemopoietic cell types including embryonic
stem (ES) cells, and cells of epithelial, mesenchymal and neuroendo-
crineorigin aswell as a comprehensive rangeof tissues. Thesedatawere
used previously to establish the specialised expression of the G protein
coupled receptor family and downstream effectors in different
hemopoietic lineages [17]. In principle, this data set provides an
unprecedented resource to examine the proposition that coexpressed
genes encode proteins involved with a speciﬁc cellular function or
pathway. It also allows exploration of the molecular basis of lineage
identity and specialisation in the hemopoietic and other cellular
systems. However, the analysis of such large data sets is challenging
using conventional approaches. In this paper we report an analysis of
the BioGPS data using the novel network analysis tool, Biolayout
Express3D [18,19]. We identify a number of co-expressed gene clusters
and show that membership of a cluster indicates the probable function
of a gene.
Methods
The data available on BioGPS include the expression proﬁles of a
wide range of tissues, including sub-compartments of organs such as
brain and intestine. The proﬁling was carried out on the Affymetrix
MOE430_2 GeneChip and normalised using MAS5 (Affymetrix, Santa
Clara, CA, USA). We selected the subset of proﬁles generated from 44
puriﬁedprimarymouse cell populations or untransformed cells and two
mouse organs, the spleen and mesenteric lymph nodes. Our group
contributed primary macrophage, osteoclast and osteoblast data to this
study; others provided mRNA from various leukocyte populations,
generally puriﬁed by FACS using lineage-speciﬁc monoclonal anti-
bodies. The actual populations analysed have been described elsewhere
[17]. In most cases, the purity and/or enrichment of the deﬁned
population was validated by examining the expression of the gene
encoding the surface antigen used in their puriﬁcation. For example,
splenic dendritic cells all expressed genes for the DCmarkers CD11c and
Flt3 at high levels, andwere distinguished by expression of genes for the
subpopulation markers CD8 and B220 (for the so-called lymphoid and
plasmacytoid populations, respectively).
The primary data were accessed from the Gene Expression Omnibus
(http://www.ncbi.nlm.nih.gov/geo/; GEO accession number:
GSE10246). The data were loaded into BioLayout Express3D [18,19], a
tool speciﬁcally designed for the visualisation and clustering of large
network graphs. A pairwise transcript-to-transcript correlation matrix
was calculated based on each transcript's proﬁle of expression across all
samples. Undirected networks with weighted edges were then
constructed using a Pearson correlation threshold cut-off of r=0.80
or 0.90, where nodes represent transcripts and edges represent Pearson
correlations above the threshold between them. The resulting graphswere then clustered using thebuilt inMarkov Clustering algorithmat an
MCL inﬂation value of 2.2 [19] which deﬁnes the granularity of
clustering. The proﬁle and gene content of each cluster was examined
in detail. Where we have presented detailed analysis of clusters, each
gene (or probe) has been individually examined on the BioGPSweb site,
to ensure that it is genuinely enriched and expressed in the cluster.
As a representative study to identify regulatorymotifs associatedwith
speciﬁc clusters, for all transcripts in the phagocyte cluster (Cluster 7),
RefSeq IDswere obtained from the Affymetrix NetAffx database (https://
www.affymetrix.com/analysis/netaffx/index.affx). Annotated transcrip-
tion start sites (TSS) were determined for these genes from the RefSeq
mm9 annotated genome (http://genome.ucsc.edu). Publicly available
cap analysis of gene expression (CAGE)-deﬁned TSSs and expression data
were obtained fromhttp://fantom.gsc.riken.jp for all mousemacrophage
libraries in the FANTOM 3 project [4,5]. For each gene, the CAGE-deﬁned
TSSwas taken as the TSS associatedwith themost abundantmacrophage
CAGE transcript within 2000 bp of the RefSeq-annotated TSS. Promoter
sequences300 bpupstreamand100 bpdownstreamof theCAGE-deﬁned
TSSswere extracted from themouse genome (mm9). Transcription factor
binding site (TFBS) motifs were identiﬁed using the JASPAR CORE 2008
motif set (http://jaspar.cgb.ki.se) and Clover (p-value below 0.01, score
threshold=6) to detect over-representedmotifs in the phagocyte cluster
promoters compared with the 2000 bp upstream sequence from all
mouse genes [20].
Results
Clustering of gene expression data from puriﬁed cell types
BioLayout Express3D is an application designed for the display and
analysis of network graphs from biologically derived data [18,19]. The
current version has been optimised for the display of very large graphs
generated from microarray expression data. It works by transforming
expression data into a network graph depicting the similarity between
individual expression proﬁles as calculated by the Pearson correlation
measure. Transcripts are represented as nodes and connected by edges
representing correlations (coexpression) above a user-deﬁned thresh-
old. Graphs generated from large expression data sets are often highly
structured, based on modules of co-expressed genes. Modules of
strongly co-expressed genes form cliqueswithin the network, structure
that can be exploited to cluster the data. The Markov clustering (MCL)
algorithm has been implemented within the tool and provides a
powerful approach for sub-dividing graphs non-subjectively into
discrete sets of genes sharing similarities in their expression i.e. clusters.
This is an unsupervised approach and clusters containing genes with
related expression proﬁles are in close proximity within the graph.
Clusters may be composed of many or just a few transcripts, being
deﬁned on the basis of connectivity and edge weights.
The networks constructed from themouse BioGPS data as described
in Methods can be downloaded and viewed from http://www.
macrophages.com. Fig. 1 shows the network constructed using a
Pearson threshold cut off of r=0.8 and a number of summarised
cluster proﬁles. Supplementary Table 1 contains a summary of all of the
individual clusters at Pearson cut offs of 0.8 and 0.9. Table 1 shows a
summary of the functional annotation of the clusters derived at a
Pearson cut off of 0.8 and index genes in each cluster. Index genes were
arbitrarily chosen based upon the knowledge of the authors, and/or a
PubMed search, as exemplars of the pathways or cell lineage-speciﬁc
functions of the set of genes within the cluster. Some of the largest
clusters appeared to be associated not with cell lineage but with broad
biological processes, including growth and proliferation (protein, RNA
and DNA synthesis and mitosis) (Clusters 1,13,25), mitochondrial
biogenesis and oxidative phosphorylation (Cluster 6), the proteasome
complex (Clusters 4,5), endocytosis and phagocytosis (Cluster 7). There
were also substantial clusters that were speciﬁcally and obviously
associatedwith specialised functionsoutsideof thehemopoietic system,
Fig. 1.Network analysis of mouse transcriptomics atlas. Samples of 44mouse cell populations and 3 tissues (lymph node, spleen, thymus) were collected and analysed on Affymetrix
MOE430 2.0 arrays in duplicate, see GEO dataset: GSE10246 (www.biogps.org). Results were normalised using theMAS5 algorithm and the tool BioLayout Express3D used to calculate
pair-wise Pearson correlation coefﬁcients for every transcript represented on the array. Using a cut off of r=0.8, a network graph was constructed whereby nodes represent
transcripts analysed on the array and edges represent relationshipsN0.80. The resultant graph was laid out in 3-dimensional space and comprised of 20,346 nodes (transcripts),
connected by 944,650 edges (main graph). The graph was then clustered using the Markov clustering algorithmwith an inﬂation value (which controls the granularity of clustering)
of 2.2. This resulted in 812 clusters containingN4 nodes. On the right of the ﬁgure are examples of these clusters shown isolated from the main graph alongside the average
expression proﬁle of the transcripts that make up the cluster. The number of transcripts in each cluster is shown bottom right next to the graph of the cluster.
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and neuroendocrine (Cluster 9, 28), muscle (Cluster 49) and epithelial/
epidermal (Cluster 16) (Table 1). For some clusters (indicated by a ? in
Table 1) annotations of genes contained within them, and/or their
average expression pattern, is not yet sufﬁcient to provide a clue as to
their shared function. A number of clusters were examined and curated
in detail as described below.
Lineage markers in hemopoietic cells
The hemopoietic clusters identiﬁed in this data set include genes that
are enriched speciﬁcally in each of the major cell types: mast cells
(Clusters 10and19), natural killer (NK)cells (Cluster34), subsets of T cells
(Clusters 14and20), B cells (Cluster 17), plasmacytoiddendritic cells (DC)
(Cluster 26), neutrophils (Cluster 15), and macrophages in various states
of activation (Clusters 12, 30, 32, 46). Cluster 12 contains many of the
genes known to be induced in a Myd88-independent, interferon-
dependent manner in response to LPS [21]. The deﬁnitive T cell subset
markersCD4, andCD8(Cd8a,Cd8b1)were restricted in their expression to
the expected subsets of cells (CD4+ or CD8+) in the primary data, and
didnot associatewith a signiﬁcant cluster of other genes. Thehemopoietic
cell clusters contained transcription factor genes that in many cases are
known regulators of lineage-speciﬁc functions (Table 1). For example,
Cluster 76 was a regulatory T cell (Treg)-enriched cluster that contained
the gene encoding the key Treg transcription factor FOXP3 as well as
known Treg functional markers CD25 (Il2ra; this protein was used in the
puriﬁcation of these cells) and the recently-described regulator GPR83
[22]. The most macrophage-enriched cluster (Cluster 32) contained the
gene for the regulator c-maf (Maf), which has been implicated in manyaspects of macrophage differentiation [23] and is required for expression
of themacrophage-speciﬁc EMR1 (F4/80)marker [24,25], also contained
within the same cluster. Genes for theknownplasmacytoidDC regulators,
Irf8 and Tcf4 [26] were joined with the marker siglech [27] in Cluster 26.
AML1 (Runx1) has been implicated in regulated expression of several
macrophage/granulocyte-expressed genes including the CSF1 receptor
gene Csf1r [28], but it clustered with the mast cell-speciﬁc genes sug-
gesting that it has novel functions in that lineage. These tight clusters
provide powerful indications that co-clustered genes of currently
unknown function are part of the innate or acquired immune response.
For example, the two large mast cell-enriched clusters (Clusters 10 and
19), that aredistinguishedbywhether thegenes are regulatedbyantigen/
immunoglobulin E, contain many genes known to function in mast cells
such as mast cell granule proteins or the surface marker, c-kit (Table 1).
They also contain many novel genes which, by association, are of likely
relevance to allergy and hypersensitivity, where mast cells are known to
be important. Again these candidates clearly warrant further study.
Phagocyte cluster
Cluster 7 is much larger, and somewhat less lineage-restricted than
the macrophage cluster 32. It contains genes highly expressed in
phagocytes and further elevated in thioglycollate-elicited peritoneal
macrophages (TEPM)andbone-resorbingosteoclasts.Manyof thegenes
in this cluster are known to be associated with endosomes/lysosomes,
including many acid hydrolases, most of the vacuolar ATPase proton
pump subunits and known membrane components of lysosomal
membranes (Lysosome-Associated Membrane Proteins, LAMPS) (Sup-
plementary Table 1). Cluster 7 was curated by examining each of the
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toeachof thegeneswithin a limited set of arbitrarily-deﬁnedcategories as
summarised in Fig. 2. Fig. 2 highlights the fact that this cluster links
together the genes that encode themembrane constituents of endosomes
and lysosomes, the synthetic apparatus required tomake theseorganelles,
and their contents (hydrolases). The cluster also contains genes that
control phagocytemotility (adhesion receptors, cytoskeletal proteins) and
that regulate phagocyte function at the plasmamembrane, the cytoplasm
and the nucleus (transcription factors). A class within cluster 7 that is not
included in Fig. 2 is the transporters and solute carriers, many of which
probably function in removing the products of endocytic breakdown from
the lysosome or the cell. So, the picture that emerges from cluster 7 is of a
transcriptional network of genes, all associated with phagocytosis in one
way or another. Within this cluster, 26 genes have no informative
annotation, and clearly warrant further functional studies in macrophage
systems.
Amongst the transcription factors enriched in cluster 7 are Sfpi1
(PU.1) and Cebpa. A recent study demonstrated that these two factors
together, when over-expressed, can convert 3 T3 ﬁbroblasts into
macrophage-like cells [29]. Many macrophage-expressed genes have a
novel promoter architecture in which a repeated purine-rich element
bound by PU.1 substitutes for the TATA box in determining the site of
transcription initiation [30]. We therefore asked whether the genes in
cluster 7 contain,within their promoters, sequence elements thatmight
be recognised and bound by one or both of PU.1 or CEBPA. For this
purpose,weextracted the region from-300 to+100of the transcription
start sites deﬁned by genome-scale 5'RACE (CAGE) analysis of mouse
macrophage cDNA. More than 1,000,000 CAGE Tags were sequenced
frommacrophage libraries by the FANTOM3 consortium [5]. Of the 469
array probes in the phagocyte cluster, 8 did not have an associated
RefSeq gene ID. For the remaining probes, 389 associated unique RefSeq
IDs were identiﬁed in the RefSeq mm9 database. For genes with more
than one annotated TSS, all annotated TSS lay within a maximum range
of 2000 bp. For 17 of the genes for which a CAGE-deﬁned TSS was
sought, noCAGETSSwas foundwithin 2000 bpof the RefSeq-annotated
TSS. Motif enrichment in this promoter set was assessed using the
Clover algorithmof Frith et al. [20]27TFBSmotifs for 15 TF familieswere
signiﬁcantly over-represented in thepromoters of thephagocyte cluster
with a positive raw score and pb0.01 (Table 2). As shown in Table 2, the
cluster was indeed enriched for candidate SPI1 (sfpi1) motifs. We have
shown previously that the purine-rich proximal promoters of myeloid-
expressed genes actually require cooperative activation by PU.1 and
another member of the ETS family, such as ETS2 or ELF1 [31]. The
phagocyte promoters are enriched also for ﬁve other Ets family motifs.
Additionally, many genes in the cluster contain E box consensus motifs
for the bHLH and bHLH-ZIP families of transcription factors. These
observations are discussed further below.
Other genes that are also expressed in a restricted manner within
phagocytes and form distinct clusters are those induced in both bone
marrow-derived, and thioglycolate-elicited peritoneal macrophages
activated by the Toll-like receptor 4 agonist, bacterial lipopolysac-
charide (LPS) (Table 1). For example, cluster 46 consists of a small list
of genes, including the gene for the inﬂammatory mediator tumor
necrosis factor-alpha (Tnf) that is induced within 2 hours of LPS
addition in both macrophage populations, and is not expressed
constitutively in other cells (Fig. 2).
Search for a stem cell signature
Clustering of the BioGPS data revealed a large, ES cell-enriched cluster
(Cluster 8) that contained genes for known regulatorsOct4 (Pou5f1), Sox2
andNanog [32,33]. This clusterwas curated in detail to conﬁrm the ES cell
enrichment. The result is themost stringent ES cell-speciﬁc proﬁle we are
aware of (Supplementary Table 2); it comprises of 136 genes, of which
around50haveno informativeannotationor aredeﬁnedonlybya speciﬁc
protein structural domain. The cluster does not contain either Klf4, orc-myc (Myc), which can contribute to reprogramming of ﬁbroblasts to ES
cells [34]. Both of these genes are actually expressed in other cell types or
tissues at higher levels, so their overexpression does not actually mimic
the natural biology of ES cells.
There has been some debate in the literature about whether there is
a gene expression proﬁle associated with “stemness”. The BioGPS data
contains two different ES cell lines, alongside many proliferating, but
relatively-undifferentiated cell populations. In a critical evaluation of
published work [35] a common stem cell signature was considered
elusive, if not illusory [36]. In the BioGPS data, genes for CD34, c-kit and
other proposed hemopoietic stem cell markers including LY6e/LY6a
(Sca1gene),HOXA9,MEIS1 andMPL [35] (whichwere sharedwithmast
cells) did not forma cluster. The tyrosinekinase gene Flt3was expressed
at a high level in puriﬁed hemopoietic stem cells (HSC, cells puriﬁed
from bone marrow on the basis of the absence of lineage markers; so-
called lineage minus cells) consistent with its function in stem cell
maintenance and mobilisation [37]. It was also expressed strongly in
all three splenic dendritic cell populations, myeloid (CD8-), lymphoid
(CD8+) and plasmacytoid (B220+). The Itga4 gene encoding the
integrin ITGA4, the only gene suggested as a candidate stem cell
signature [36], was not enriched in HSC andwasmore highly expressed
in most mature cell types other than mast cells.
Analysis of a mesenchyme-speciﬁc cluster
A large set of genes which were highly expressed in all of the
mesenchymal cell types (851 nodes, comprising 589 genes) formed
cluster 2 (Supplementary Table 1). The genes in cluster 2were excluded
from any of the hemopoietic cell types, from epithelial (mIMD3) or
neuronal (Neuro2a) cells and were expressed at only low levels in ES
cells. As with the phagocyte and the different hemopoietic lineage
clusters, within the mesenchyme cluster, there were many transcripts
with uninformative nomenclatures that can now be inferred to function
in mesenchyme biology. When the expression data were examined at
the higher Pearson cut off (r=0.9), cluster 2 divided into two large
clusters (sub-clusters 3 and 5 shown in Supplementary Table 1), each
with around 200 transcripts. The genes in each cluster were distin-
guished by their relative enrichment in ﬁbroblast cells and osteoblasts,
respectively. Many members of both these sub-clusters have no
informative annotation, most being identiﬁed by RIKEN numbers. The
majority are annotated as extracellular in Gene Ontology. Many of the
intracellular or transmembrane proteins are probably involved in the
secretory pathways for these extracellular proteins. For example, around
10% of the annotated genes of sub-cluster 3 encode proteins of the
endoplasmic reticulum (including trafﬁcking proteins and molecular
chaperones), suggesting that individual processing enzymes have
particular roles in the secretion of proteins of the extracellular matrix.
The BioGPS dataset analysed here contains a time-course of differenti-
ation and calciﬁcation of primary calvarial osteoblasts in response to
ascorbate and glycerophosphate, as described in Chang et al. [38]. A
subset of the genes in the cluster are induced as these cells differentiate
and these genes are candidates for direct or indirect involvement in the
regulation of matrix calciﬁcation. The osteoblast-enriched cluster has
been curated and annotated in Supplementary Table 3.
As discussed for the clusters restricted to phagocytes, the embryonic
stem cells and the various subpopulations of other cells of the immune
system, the mesenchyme cluster contains many genes encoding known
or putative transcription factors, including members of several tran-
scription factor families (Snail, Twist, Prrx, Nfat, Id, Sox) known to
regulate mesenchyme differentiation or function [39]. It also contains
genes encodingknownmesenchyme regulators (TGFs, secreted frizzled-
like proteins), G-protein coupled receptors and receptor tyrosine
kinases. A number of the genes in this cluster, including Fbn1 which is
mutated in Marfan syndrome in humans [40] and several of the
collagens, are well known to be associated with genetic abnormalities
affecting connective tissues. By their coexpression association, other
Table 1
Annotation of Coexpressed Gene Clusters. Clusters generated from the BioGPS data set using Biolayout Express 3D, (GNFv3_cells_8P_22MCL; Supplementary Table 1) were individually curated and annotated based upon examination of the
average expression proﬁle (see Fig. 1), GO terms, and biological knowledge. Index genes were chosen to represent known lineage or functional markers within the cluster.
Cluster
no.
Mean proﬁle description Putative function or cell lineage Index genes Other relevant genes Enriched gene families
1 General, high in progenitors, DCs, lymphocytes G1 growth Creb1, Ccnd3, Elk4
2 High in osteoblasts, ﬁbroblasts, CH3 Mesenchyme Snai2, Fbn1, Fzd1 Fzd2,7 and 8, Nfatc4, Snai1, Tbx15,
Twist1, Nﬁx
Collagens/frizzled homologs/matrix
metallopeptidases/Rabs/Tgfbs/thromospondins
3 High in Min6 Neuronal/synaptic/insulin secretion Pax6, Nfasc Myt1, Nrtk2, Pax4, Pdx1 Cadherins/gluamate receptors/potassium channels/
synaptotagmins
4 General, high in ES cells RNA and protein synthesis/G1/
proteasome
Ccnb1, Gspt1 Btf3, Ilf2, Cdk4, Polr2e Eurkayotic translation initiation factors/mitochondrial
ribosomal proteins/nucleoporins/Proteasome/nucleolar proteins
5 General, high in progenitors Ribosome and RNA processing/
proteasome
Rpl115, Sf3a1 Ewsr1, Mapk1, Ccne1, Elf2 Chaperonin subunits/eurkayotic translation initiation
factors/mitochondrial ribosomal proteins/polymerases
6 General, low in progenitors, DCs, lymphocytes Membrane biogenesis/secretion/Ox.
Phos
Snx12, Vps24 Tcfe3, Bax, Arf2, 4 & 6, Akt1, Akt2 Dynactins/Rabs/ring ﬁnger proteins
7 High in macs populations, periNBMDM Late endosome/lysosome/phagocytes Ctsb, Cd68, Capg Atf3, Cebpa, Sfpi1(PU.1), Nfe2l2 H+ transporters/cathepsins
8 High in ES cells ES Cell Nanog, Pou5f1, Sox2, Fgf4 Foxd3, Gbx2, Klf5, Nrob1, Nr6a1, En2,
Tbx3
Developmental pluripotency associated/ﬁbroblast
growth factors/forkhead box
9 High in Neuro2a≫Min6 Neuroendocrine/secretion Dhh, Gh Enc1, Gata4, Prkcz ELAVs/microtubule associated/
10 High in mast cells Mast cell granules Cma1, Cpa3, Runx1 Tal1, Scl, Gata1 Rho GTPase activating/guanine nucleotide binding/mast cell
proteases
11 General, highest in ES cells, progenitors, cell lines S phase-related Cdc20, Pola2 Tcp1, Elac2 DEADs/MCMs/nucleoporins/polymerases
12 High in stimulated macrophages Late LPS-inducible, interferon Cd40, Myd88, Irf7, II1a Lhx2, Stat2, Nfe2l1 CXCLs/interleukins/OASs/interferon induced
13 General, high in progenitors, DCs, lymphocytes RNA processing and protein translation Bub3, Hnrpc, Polg2, Sp1, Yy1 Splicing factors/DNA–RNA polymerases/heterogenous
ribonucleoproteins
14 High in T-cellsNB-cellsNDCs T cell-speciﬁc Lef1, TCR, Cd3, Cd2 Tcf7, Satb1, Ets-1, Foxo1, Gata3, Limd2,
Mllt3
T-cell receptors
15 High in granulocytesNbone marrow Granulocyte Ch3L1, Ccr1, Ccr1, Csf3r, Mmp9 Matrix metallopeptidases/CEACAMs
16 High in mlMCD-3 Epithelial/epidermal Hoxb2, Wnt7a, Krt8 Col4 family Cluadins/HOXs/keratins
17 High B-cellsN lymph node/spleenNDCs,
FoxP3 T-cells
B cell/DC; APC CD19, , Cd79a, Ig, Mef2c, Pax5 Ikzf34, Spib, Pou2f2 (Oct2), Irf4, Foxp1 MHC class II/immunglobulins
18 High in bone marrow≫erythrocyte progenitors Erythroid/megakaryocyte/eosinophil/
marrow
Epor, Epx, Sox6 Sox6, Tfdp2, E2f4, E2f8
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Table 1 (continued)
Cluster
no.
Mean proﬁle description Putative function or cell lineage Index genes Other relevant genes Enriched gene families
19 High in mast cells Mast cell membrane Kit, Lif, Pgr Ikzf4, Gata2, Runx1, Csf2rb, Il4ra
20 General, high NK cellsN lymphocytes, DCs,
progenitors
? Nfatc1, Map3k1
21 High in thymocytes Recombination/double-positive
thymocytes
Cd8, Ccr9, Rag1, 2 Nrf1
22 General, low in progenitors, DCs, lymphocytes Ox. Phos/mitochondrial Dufa4, Cox8a, Mrpl20 Atf2
23 General, high in lymphocytesNDCs, granulocytes Signalling complex/pathway Traf3, Traf5, Irf3, Slamf6
24 High in lymph nodeNspleen Lymph node/lymphocyte/lymphatic Ig, Cd209, Madcam1, Lpr
25 General, highest in ES cells, progenitors, cell lines S phase Bub1, Ccne2, Dhfr, Orc1l, Pola1
26 High in plasmacytoid DC≫DCs, B-cells Plasmacytoid DC markers Irf8, Lifr, Tlr7, Tcf4, Clec4g
27 High in Neuro2aNother cell lines, osteoblasts ? Tln2, Pfn2
28 High in Neuro2a, Min6 Neuronal/secretory/channels Gabrb3, Rims2, Scn8a
29 General, highest in B-cells ? Foxp1, Sod1
30 High in stimulated macrophages Residentmacrophage/late LPS-response Csf3, Fcgr1, Tcfec, Nos2 (iNos),
Ptges
Socs3, Irak2, Irak3, Mk2
31 High in C2C12 Early muscle (C2C12) Myf5, Myod1
32 High in macrophage populations, BMDMNperi Macrophage-speciﬁc Cd14, Emr1, Maf
34 High in NK cells≫DCs NK cell-speciﬁc, killing pathway Fasl, Gzma, Klra1, Cd160, Prf1 Il18r1, Il2rb
36 High in B-cells B-cell speciﬁc Ebf1, Cd38, Foxp1
38 General, high expression Ribosome Rpl7, Rps10, Rps15
41 High in erythroid progenitorNbone marrow Erythroid progenitor Klf1, Car1/2, Trfr2
42 High in 3T3NC2C12, C3H, osteoblasts Wnt signalling (caveolin) Smo, Axl, Gli3, En1
43 High in ﬁbroblasts≫osteoblasts Fibroblast/osteoblast Bmp4, Fbn2, Cdh10 Egr1, Egr2, Klf6, Junb, Rel,
45 High in lymphoid CD8+ DCNCD8− DC Lymphoid CD8+ DC, melanocytes? Tyr, Si, Mlana
46 High early in LPS stimulated macrophages Early LPS response/proinﬂammatory Tnf, Egr1, Ifnb1
49 High in stimulated osteoblasts/C2C12 myoblasts Muscle contractile function Myh1, Myog
51 High in 3T3-L1Nstimulated osteoblasts Differentiating mesenchyme Ghr, Pdgfra, Tgfbr3
53 High in spleen Pancreatic enzymes (contaminant
of spleen)
Ela3, Cpa1
66 High in LPS stimulated macs, DCs, lymphocytes Interferon pathway Stat1, Iﬁ203
67 High in lymphoid CD8+ DCNspleen Myelin/myelination Mbp, Plp1
73 High in microglia Glia-speciﬁc (contamination
of microglia)
Gfap, Fabp7, Olig1
76 High in T-cells, thymocytes Regulatory T cells (Treg) Foxp3, Gpr83, IL2ra Pdcd1, Tnfrsf4 (CD134/Ox40),
Icos, Slamf11
80 High in B-cells, DCs, spleen, lymph node Class II MHC antigen presentation Ciita, MHCII family CD74
88 High in progenitors Neutrophil granule Mpo, Ctsg, Ela2
163 High in osteoclastsNLPS induced peritoneal-
macrophage
Osteoclast-speciﬁc Calcr, Oscar, Acp5
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Fig. 2. Annotation of a cluster of genes enriched in phagocytes. Geneswithin cluster 7 (Supplementary Table 1), which is enriched in phagocytes (macrophages, osteoclasts, microglia
and RAW264 cells) were individually checked on BioGPS. Genes that were expressed below the median in the macrophage samples, and at least 3X the median in at least one non-
macrophage tissue sample (tissues that were not used in the clustering) were removed. Many genes removed had obvious tissue-speciﬁc functions, but were also expressed
detectably in macrophages. Individual genes of known function were then assigned to a speciﬁc category as shown, based upon annotations available on BioGPS, or individual
literature search on PubMed. Boxes broadly classify genes into signalling/regulation, internalisation, vesicle formation/acidiﬁcation and digestion. The central image shows a mouse
bone marrow-derived macrophage stimulated with lipopolysaccharide for 4 hours and stained with FITC-phalloidin (to mark the cytoskeleton) and Cy3-anti-tumor necrosis factor-
alpha which marks the Golgi apparatus. The box above this image contains the set of early response genes that is coexpressed with Tnfa.
334 D.A. Hume et al. / Genomics 95 (2010) 328–338genes in the cluster would also be expected to be linked to such diseases
[9].Wehaveexamined this propositionbyassessing theentries for genes
in the high stringency sub-clusters in OMIM (www.ncbi.nlm.nih.gov/
omim). Of 168mesenchyme-expressd genes with an entry in OMIM, 60
were associatedwith a phenotype inmouse (42) or human (29) or both.
Of these, bones, skin, eyes and blood vessels were most frequently
affected in humans, and bones, blood vessels and lung were most
frequently noted for mouse (Summers et al, Ms in revision). These
results are consistent with a critical role for these genes in development
of mesenchyme-derived tissues.
Discussion
General overview
This study demonstrates the utility of large collections of gene
expression data in examining relationships between tissues or cells
through the cohorts of genes they express. It also demonstrates the
potential to characterise as yet unannotated proteins because the likely
function or process in which they are involved can be inferred by their
coexpression with genes encoding proteins of known function.
Visualisation and analysis of data as networks is becoming an
increasingly important approach in the exploration of relationships
between entities in a wide variety of different ﬁelds. Network analysis
techniques allow the exploration of the position of a unit in the context
of its local neighbourhood in the graph, and in the network as a whole.
We have developed a new approach to exploring expression data basedonmeasuring the correlationbetweenexpressionproﬁles andusing this
measure to construct a large networks of the expression “distance”
between genes. The construction, visualisation and clustering of these
graphs is supported by BioLayout Express3D, the only network analysis
tool available that is capable of rendering network graphs of this size.
The clear biological unity of the clusters we have generated illustrates
the effectiveness of this approach.
Although cluster analysis usingBioLayout Express3D on large datasets
is remarkably powerful, only aroundhalf of the genes on the arrayswere
within clusters using the criteria we have used. That does notmean that
the excluded genes are outside synregulatory groups. Our illustrative
analysis has used arbitrary parameters and focussed on a large but
nevertheless limited number of pure cell populations. There are many
lineage-speciﬁc or tissue-restricted genes we have excluded by not
considering the data sets from whole tissues and various stages of
embryogenesis that are available on BioGPS. Clusters generated in
tissues can potentially include genes expressed in one cell type that are
regulated by products of another cell. So, they need not share
transcriptional regulatory pathways. Nevertheless, the most recent
data on BioGPS are more extensive than the original tissue data of Su et
al. [7,8] (available on the same site). Many of the genes that have not
been clustered in Supplementary Table 1 are actually expressed in a
tissue-speciﬁc manner and would form informative clusters if we
included the tissues in a larger network graph, for example being
enriched in the central nervous system, in gut, muscle or liver [7,8].
Thewide diversity of puriﬁed cells that have beenpolled in the BioGPS
data set range fromquiescent lymphocytes to proliferatingﬁbroblasts and
Table 2
Statistically over-represented motifs identiﬁed using Clover. Over represented motif famlies
are highlighted. Raw scores quantify the degree of over-representation of motifs compared
to the background set of all mouse promoters (2000 bp upstream of annotated mouse
transcription start sites); p-values report the probability of obtaining this raw score by
chance (calculated by randomly sampling the background set). Colors group related
motifs.
335D.A. Hume et al. / Genomics 95 (2010) 328–338phagocytic macrophages. Independently of their cell lineage, they clearly
vary in their engagementwithgrowthandproliferation (protein, RNAand
DNA synthesis and mitosis), mitochondrial biogenesis and oxidative
phosphorylation, the cytoskeleton, the proteasome complex, endocytosis
and phagocytosis. Genes associated with these processes are clustered
together, and this clearly provides a very powerful annotation tool for the
many genes of unknown function that are found on the arrays, identiﬁed
only by a RIKEN number or other functionally uninformative identiﬁer.
Such informationmay complement efforts such asMouseNet [32], which
aim to produce functional networks of mammalian gene interactions
based upon protein interaction and pathway information.
Our analysis shows that a powerful driving force behind functional
annotation of mammalian genes has been the identiﬁcation of genes that
are restricted in their expression to a certain lineage or state of
differentiation or activation. This is evident from the high proportion of
genes of unknown function or ambiguous or uninformative annotation in
the larger clusters (1,4,5,6,11,13,22,23,25) to which we have somewhat
arbitrarily ascribed a function. Only cluster 25 has a clear function, since it
is enriched for genes involved in DNA replication and S phase of the cell
cycle. There is a higher proportion of fully annotated genes in the cell or
tissue speciﬁc or regulated clusters: it seems that “ubiquitously-
expressed” has been synonymous with “not very interesting”.
Gene regulation and the phagocyte cluster
Our detailed annotation of the phagocyte cluster, cluster 7 (Fig. 2,
Supplementary Table 1), complements and extends the recent study of
Sardiello et al. [41], who published an analysis of endosomal gene
expression in a human system. The gene set of cluster 7 differs from theirs
in that it contains many cell surface receptors, regulators, signalling
molecules etc (Fig. 2) that are characteristic of a phagocyte, and therefore
correlated with lysosomal gene expression. Many of these genes are
clearly needed in order for a phagocyte to produce lysosomes, so one
might argue that they are part of a pathway and would be coordinately-
regulated. Sardiello et al. [41], identiﬁed lysosomal genes based upon arelatively simple correlation analysis with a number of known lysosomal
genes across a large set ofmiscellaneous tissue and cell array proﬁles; it is
not clear whether they included puriﬁed macrophages. They then
analysed the promoters of the putative human lysosomal genes, and
identiﬁed E-boxmotifs (CAnnTG) in the promoters of a substantial subset
of them. Our analysis of motif overrepresentation in the promoters of the
phagocyte cluster (Table 2), which identiﬁed 6 variants of the E box
targets of bHLH and bHLH-ZIP factors, conﬁrms and extends this
observation to the larger set of genes that deﬁnes a phagocyte. Sardiello
et al. showed that a speciﬁc E-boxbinding transcription factor, TFEB, could
activate expression of lysosomal genes when overexpressed in HeLa or
HEK293 cells. The related proteins in the bHLH-ZIP family,MITF, TFEC and
TFE3, couldnot activate lysosomal geneexpression. TheTfebgene isnot, in
fact, part of the Cluster 7, arguing that it is not the lineage-restricted
regulator of this set of genes. In the BioGPS data it is expressed in
phagocytes alongside all three of the other members of the bHLH-ZIP
(MITF) family, consistent with previous ﬁndings [42]. In fact, the three
other family members can form functional heterodimers that activate
lysosomal genes like Acp5 [43]. So, although they did not activate the
lysosomal cluster on their own in the published study [41], the fourMITF-
related familymembers probably act together on the shared E-boxmotifs
within this family of coregulated genes. Themicrophthalmia transcription
factor itself (Mitf) is implicated in melanocyte, cardiac, mast cell,
macrophage and osteoclast gene expression [44–46]. Mitf is also not a
member of any cluster, because it is expressed inmacrophages, microglia
andosteoclasts (but not inDC), aswell asmast cells and cells of the retinal
pigment epithelium, a pattern that is unique to this gene. Several of the
genes shared by cluster 7 and the putative targets of TFEB; namely Acp5,
Clcn7 and Ostm1, are actually validated targets of MITF acting in
partnership with the phagocyte transcription factor SFPI1 (PU.1) [43].
Sfpi1 and the gene formacrophage-expressed factor, Cebpa, are contained
with cluster 7. A recent study demonstrated that these two factors
together, when over-expressed, can convert 3 T3 ﬁbroblasts into
macrophage-like cells [29]. The promoter analysis of the cluster 7 genes
(Table 2) identiﬁed over-representation of both ETS/PU.1 and CAAT box
(C/EBP target) motifs in the proximal promoters. Also over-represented
within the cluster were so-called b-ZIPmotifs, which could be recognised
by the CREB/ATF family (including ATF3, which is itself within cluster 7)
and c-MAF/MAFB, which are within a macrophage-speciﬁc cluster and
implicated in macrophage differentiation [23].
The lysosome is also an organelle that has been studied using
proteomic approaches, and implicated in human lysosomal storage
disease (Table 1. of Ref [47]).Many lysosome-associated geneproducts
share a targeting motif, mannose-6-phosphate, that is added to the
protein post-translationally Lubke et al. [47] summarise candidate
lysosome-associated genes identiﬁed by puriﬁcation and mass
spectrometry based upon the presence of mannose-6-phosphate.
They argue thatmany of these genes have been incorrectly assigned to
other cellular locations. Yet, although cluster 7 contains the mannose-
6-phosphate receptor gene (M6pr) and mannose-6-phosphate bind-
ing protein 1 gene (M6prbp1), it does not contain genes for any of the
30 candidate proteins discussed by these authors. Membership of
cluster 7 may provide a stronger indication of a likely lysosomal
function of many genes with uninformative annotation; for example
the cluster contains the gene for the protein GPNMB, a macrophage
and osteoclast-enriched CD68-like protein [48], which is also an MITF
target and was predicted to reside in the endocytic pathway of mature
macrophages [49].
Markers in hemopoietic lineages
The use of cell surface markers for ﬂow cytometry or identiﬁcation
of cells in tissues is based tacitly on the assumption that the surface
marker correlateswith a cellular function. This can really only be the case
if the marker is associated with a cluster of coexpressed genes. Our
cluster analysis suggests that this prediction is commonly not the case.
336 D.A. Hume et al. / Genomics 95 (2010) 328–338Even the deﬁnitive T cell subset markers CD4 and CD8 (Cd8a, Cd8b1),
whichare clearly restricted in their expression to the expected subsets of
cells (CD4+ or CD8+) in the primary data on BioGPS, do not associate
with a signiﬁcant cluster of other genes. Indeed, a recent study of human
peripheral T cells has conﬁrmed that the basal expression patterns of
CD4 and CD8-positive cells are very similar; although their patterns
diverge somewhat upon stimulation [50]. That ﬁnding suggests that
naïve T cells might have no functional specialisation other than their
expression of a particular receptor complex that generates a distinct
signal. The clusters generated using BioLayout Express3D and the BioGPS
data are much tighter, and more biologically cohesive, than those
derived from cluster analysis of human peripheral blood mononuclear
cells [13]. Notwithstanding the discussion above of transcription factor
interactions, in each of the clusters derived from BioGPS data, there are
transcription factor genes that in many cases are known regulators of
lineage-speciﬁc functions (Table 1). This is a particular advantage of
working with puriﬁed primary cells; a greater proportion of transcrip-
tion factor genes have mRNA levels within the reliable detection range.
For example, cluster 47 is a regulatory T cell (Treg)-enriched cluster that
contains the Foxp3 gene, encoding the key Treg transcription factor, as
well as genes for knownTreg functionalmarkers CD25 (Il2ra) andGpr83.
One issue of particular interest to immunologists is the relationship
of macrophages to myeloid DC. Myeloid DC are certainly members of
the so-called mononuclear phagocyte lineage that share committed
progenitor with monocytes and macrophages [3,51]. The BioGPS data
set contains expression proﬁles of highly-puriﬁed myeloid and
lymphoid DC (CD11c+, CD8- or CD8+) from spleen, alongside
plasmacytoid DC. DCs are thought to by some to be specialised
antigen-presenting cells [3,51]. The DC subpopulation expression
proﬁles were internally validated by strong expression of genes
encoding the surface markers that were used in their puriﬁcation:
CD11c (Itgax) and CD8A. However, neither the genes encoding these
proteins, nor any of the genes encoding putative functional markers of
myeloid DC such as the C type lectins DEC205 (Ly75, Clec13b, CD205),
DC-SIGN (Clec4L, CD209a) or langerin (Clec4k, CD207) [3,51], clustered
together in a well-deﬁned group that would provide an antigen-
presenting cell signature, although each was highly expressed in one
or all of the puriﬁed DC subsets. Many class II MHC genes clustered
with the known regulator Ciita and Cd74 in a shared B cell/DC/
antigen-presenting cell signature along with a number of antigen
processing enzymes (cluster 80). The favoured DC marker in the
mouse, CD11c (Itgax), did not cluster with any other marker,
consistent with it being widely expressed amongst hemopoietic cells
[3,51]. As noted above, all three populations share high expression of
Flt3, as would be expected [52–54] and there was a very clear
plasmacytoid DC signature (cluster 26). If there is actually a myeloid
DC signature, or a set of genes required for antigen presentation, itmay
be more accurately deﬁned by the comparative lack of expression of
macrophage-speciﬁc genes and the phagocyte-associated genes in
cluster 7, a criterion thatwas actually used in the original identiﬁcation
of these cells [3,51].The impact of alternative promoter use on gene expression and clusters
CSF-1 controls thedifferentiationofmacrophages andDC[55] but the
CSF-1 receptor gene (Csf1r) is not a part of phagocyte cluster 7, nor the
macrophage-speciﬁc cluster 32, because it is expressed at the mRNA
level in other cell types, notablygranulocytes,DC,NKcells andregulatory
T cells. Csf1r is just one of many examples in which the level of mRNA
does not necessarily correlate with production of the protein [56], and
the relationship between the transcriptome and proteome is a new
frontier for systems analysis. The unique pattern of expression of Csf1r is
also partly due to the fact that it has at least three separately regulated
promoters ([57] and unpublished), active in macrophages, osteoclasts
and trophoblasts. Another example of dissociation of function fromexpression is the family of genes required for osteoclastic bone resorp-
tion, many of which are targets ofMitf as discussed above.
Over half of the protein-coding genes in the mouse genome have
more than one promoter [4,5]. Mitf is itself an example. The deﬁnitive
osteoclast marker and MITF target, tartrate-resistant acid phosphatase
(Acp5) [46] has at least 4 separate promoters, used in different cell types
[58]. Acp5 does not correlate with Mitf expression or other osteoclast
functional genes (e.g. cathepsin K, Ctsk) because only one of the pro-
moters is MITF-responsive, MITF regulates gene expression in the other
cell types mentioned above, and Mitf is itself expressed from different
promoters [44,45]. The confusionof clustering that arises from theuse of
distinct promoters in different cell types will likely be resolved with
CAGE, a genome scale 5' RACE technology, which permits quantitative
determination of TSS use and allows clustering of co-expressed pro-
moters, rather thanmRNAs [4,5]. For example, gelsolin (Gsn) appears to
bewidely expressed and is not part of any cluster. CAGE tag sequencing
revealed that expression in macrophages is derived almost exclusively
from a distal macrophage-speciﬁc promoter. The different promoters
regulatingGsn also produce different forms of the protein, a cytoplasmic
actin regulator in macrophages, and a secreted plasma protein in many
other cell types [59]. If we are able to repeat the current cellular clus-
tering based upon shared CAGE Tag cluster expression, as previously
done with predominantly tissue-derived CAGE data [4], Gsn would
undoubtedly cluster with genes encoding cytoskeletal regulators, in-
cluding the related CapG protein, which are found within the macro-
phage-enriched endosome cluster (cluster 7) because of their direct
involvement in phagocytosis [59]. A detailed network analysis of human
macrophage differentiation using CAGE showed that precise deﬁnition
of the transcription start site expedites the identiﬁcation of shared
functional promoter motifs that underlie co-expression in gene clusters
[60].
Reinterpreting tissue microarray data based upon cluster signatures
We have re-evaluated other publicly available data sets using a
network clustering approach.We analysed a large human breast cancer
data set [61], and detected a cluster of genes that included the macro-
phage speciﬁc genes CSF1R, CD14 and CD11B (ITGAM). This cluster can
therefore be inferred to, and does, contain other genes that are speciﬁc
to the macrophage component of the tumor. The clustering of
macrophage-speciﬁc genes using RNA extracted from tumor samples
indicates that expression levels vary, presumably in proportion to the
numbers of macrophages in the tumor samples.
The same approach was applied to other data sets to assess whether
the cellular composition varied substantially between samples. For exam-
ple, one mesenchyme-speciﬁc cell population that is not in the BioGPS
data set is chondrocytes. There is a published microarray study of the
differentiation of these cells in cultures derived from embryonic mouse
foot pads, and most of the genes identiﬁed in the mesenchyme cluster
(cluster 2) are expressed at high levels in these cells (not shown). Mouse
footpads contain very large numbers of macrophages involved in elimi-
nation of dying cells between the developing digits and other morpho-
genic events [62]. In the chondrocyte differentiation data set, there was
expression of many members of the macrophage-speciﬁc cluster 32
(exempliﬁedbyCd14, Emr1), aswell asCsf1r, increasingwith time [63]. So,
we can infer thatmacrophages derived from the interdigital regions of the
footpads survive and proliferate in culture and are involved in this
differentiation system. This is consistent with a recent study where we
showed that standardmethods for producing primary calvarial osteoblast
(mesenchymal) cultures generate a self-sustaining macrophage contam-
inant derived from the bone-associated macrophage pool in vivo and
essential for calciﬁcation [38]. We provided two sets of RNA to the GNF
group, from primary calvarial osteoblasts (Symatlas; GNF1M) and the
same cell population in which the macrophages had been removed
(BioGPS; MOE430). The former shows expression of macrophage-asso-
ciated genes in clusters 7 and 32 within the osteoblasts, while the latter
337D.A. Hume et al. / Genomics 95 (2010) 328–338does not. Thus examination of gene expression clusters can provide
information about the biological processes acting in different cellular
situations.
Conclusion
Clustering of the BioGPS data suggests that markers are only
informative if they are linked to function. Class II MHC molecules are
linkedwith antigen presentation, but CD11c (Itgax), is not correlatedwith
any other set of genes. Even focussing solely on the cellular set, for any
gene of interest it can be informative to identify genes that are correlated
across very large data sets. In the future, with tools like BioLayout
Express3D we can imagine poolingmassive datasets from public data such
as the Immunological Genome Project [15], merging technologies such as
CAGE and promoter motif analysis and including much greater ranges of
cells and tissues in various states. It is clear that we can learn a great deal
about a gene from the company it keeps. Our own engagement with this
process includes the establishment and development of a database at
http://www.macrophages.com in which we will develop precomputed
networks and clusters incorporating other large datasets.
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